The treatment plan included the initiation of GLP-1 therapy, complemented by a personalized dietary regimen aimed at improving her nutrition and addressing her overeating habits
In Vitro Metabolism of the Glucagon-Like Peptide-1 (GLP-1)Derived Metabolites GLP-1(9-36)amide and GLP-1(28-36)amide in Mouse and Human Hepatocytes
According to the National Institute on Drug Abuse (NIDA), persistent cravings are a hallmark of substance use disorder and indicate a growing dependence on the medication
Now, when we get into this new paper of yours, the proteomics, can you tell us about that because that's really exciting
However, some individuals might experience mild gastrointestinal side effects, such as nausea, bloating, or diarrhea, especially as their body adapts to the medication